Opus Genetics IRD Weighted average grant date fair value (in USD per share)
Weighted average grant date fair value (in USD per share) at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept ird:ShareBasedCompensationArrangementByShareBasedPaymentAwardServicesGrantsInPeriodWeightedAverageGrantDateFairValue.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's weighted average grant date fair value (in usd per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Opus Genetics's weighted average grant date fair value (in USD per share)?
- Opus Genetics (IRD) reported weighted average grant date fair value (in USD per share) of $2.01 in Q1 2026.
- How has Opus Genetics's weighted average grant date fair value (in USD per share) changed year-over-year?
- Opus Genetics's weighted average grant date fair value (in USD per share) increased by 59.5% year-over-year, from $1.26 to $2.01.
- What does weighted average grant date fair value (in USD per share) mean?
- The weighted average fair value of equity-based awards granted to employees or directors as of the date of the grant. This metric provides insight into the cost-basis of compensation packages and the potential future dilution impact on existing shareholders.